Regulatory Affairs & Product Registration involves preparation, review, submission, and maintenance of regulatory documentation required for approval of pharmaceutical products in different markets.
Regulatory compliance is essential for successful product registration and uninterrupted market supply. Properly structured submissions help reduce deficiencies, improve review timelines, and support smooth communication with regulatory authorities.
Our support includes CTD/ACTD dossier preparation, API regulatory documentation, CDSCO filings, global registration planning and post-approval lifecycle management activities.
Guidance for pharmaceutical companies registering products, preparing CTD/ACTD dossiers, and managing API submissions across regulated markets.
This support is generally required in the following situations:
Practical regulatory documentation support aligned with current submission requirements across target markets.
Our approach focuses on preparation of technically consistent and submission-ready documentation.
Depending on project scope, deliverables may include:
Practical support for pharmaceutical regulatory documentation, dossier preparation, and submission readiness across multiple markets.
FAQ
Yes, we support both formats based on country requirements.
Yes. Support is provided for USDMF, CEP, and ASMF-related documentation activities.
Yes. We support import license, CT-06 filing, and related CDSCO documentation activities.
We support compilation and integration of available non-clinical and clinical data.
Tablets, capsules, ointments and sterile injections.
Yes, we provide a detailed gap assessment and technical review.
Yes. We assist in preparing responses to authority queries and deficiency letters.
We adapt dossiers as per regional guidelines and submission formats.
Usually 4–8 weeks depending on data availability and complexity.
Yes. Support can be provided for query response and dossier updates.
Fill in the form and our team will get back to you shortly.
Reach our regulatory experts directly.